GSK GlaxoSmithKline plc ADR

在31/12/2022結束的金融年度: GlaxoSmithKline plc ADR的營收decreased by 23.01% ，達到 36.12B。淨利decreased by 13.51%至6.06B。淨資產decreased by NaN到12.14B；每股盈餘從N/Adecreased到9.02。